Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10537 - 10544 of 11439 results
FLSA Class Actions: Recent Seventh Circuit Decision Points To Merger Of Certification Standards
April 9, 2013| Blog| Viewpoint
H-1B Cap Hit for Fiscal Year 2014
April 8, 2013| Blog| Viewpoint
Health Care Services Providers to Federal Health Plan Members Subject to Federal Affirmative Action Compliance Audit
April 8, 2013| Advisory| Viewpoint
Negligent Credentialing Claim Recognizable Under Massachusetts Law
April 8, 2013| Blog| Viewpoint
Extension of EHR Donation Sunset Date Proposed by OIG/CMS
April 8, 2013| Blog| Viewpoint
To Release Or Not to Release – If That Is the Question, What Is the Answer?
April 5, 2013| Advisory| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.